One MSH2 mutation was detected in a patient with an endometrial tumour diagnosed at age 39 that was tested MSI negative without loss of MLH1, PMS2, MSH2, or MSH6 protein staining. This evidence concerns the gene MSH2 and endometrium neoplasm.